← Back to Search

Breathing Training for Bronchiectasis

N/A

Recruiting

Led By Bryan Taylor, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 8 weeks

Awards & highlights

Study Summary

This trial looks into using breathing and muscle exercises to improve exercise ability, lung function, and general health for people with non-CFB.

Who is the study for?

This trial is for Mayo Clinic patients with non-cystic fibrosis bronchiectasis (non-CFB), who can consent to participate. They should be stable, without exacerbations or changes in therapy for three weeks and not have heart failure, major diseases, neurological conditions, orthopedic issues affecting exercise, recent pulmonary rehab participation or current antibiotic use.Check my eligibility

What is being tested?

The study tests a home-based breathing training program supported by health coaches. It aims to see if this LungTrainers Pulmonary Rehabilitation regime improves exercise capacity, lung and respiratory muscle function, and overall clinical status in individuals with non-CFB.See study design

What are the potential side effects?

While the trial description does not specify side effects directly related to the interventions being studied (LungTrainers regime), typical concerns may include muscle soreness or fatigue from new exercises.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in peak oxygen uptake during maximal incremental exercise test

Change in six-minute walk test distance

Secondary outcome measures

Change in Dartmouth COOP Functional Assessment Charts

Change in Modified Medical Research Council Dyspnea Scale (mMRC)

Change in St. George's Respiratory Questionnaire (SGRQ)

+10 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Home-based specific breathing and respiratory muscle training groupExperimental Treatment2 Interventions

In addition standard of care pulmonary rehabilitation, subjects will participate in an 8-week home-based specific breathing and respiratory muscle training via the LungTrainers Pulmonary Rehabilitation regime (LT-PR).

Group II: Control group of standard physician directed careActive Control1 Intervention

Subjects will receive pulmonary rehabilitation via standard physician directed care (i.e., 'normal care').

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,216 Previous Clinical Trials

3,767,438 Total Patients Enrolled

3 Trials studying Bronchiectasis

155 Patients Enrolled for Bronchiectasis

Bryan Taylor, PhDPrincipal InvestigatorMayo Clinic

2 Previous Clinical Trials

80 Total Patients Enrolled

1 Trials studying Bronchiectasis

30 Patients Enrolled for Bronchiectasis

Media Library

LungTrainers Pulmonary Rehabilitation regime Clinical Trial Eligibility Overview. Trial Name: NCT05860803 — N/A

Bronchiectasis Research Study Groups: Control group of standard physician directed care, Home-based specific breathing and respiratory muscle training group

Bronchiectasis Clinical Trial 2023: LungTrainers Pulmonary Rehabilitation regime Highlights & Side Effects. Trial Name: NCT05860803 — N/A

LungTrainers Pulmonary Rehabilitation regime 2023 Treatment Timeline for Medical Study. Trial Name: NCT05860803 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical study accept participants younger than 45 years old?

"According to the stipulated criteria, prospective participants must be aged 21 or higher and not exceed 80 years old."

Answered by AI

Am I eligible to partake in this research?

"To be eligible, potential participants must possess a diagnosis of bronchiectasis and fit within the age range of 21-80. The research team is hoping to enroll up to fifty individuals in total."

Answered by AI

What are the underlying aims of this analysis?

"This trial, which will span from Baseline to 8 weeks, seeks to measure Change in peak oxygen uptake during maximal incremental exercise test. Secondary outcomes include Change in exercise time during maximal incremental exercise test (Max volume or amount of oxygen consumption during cardiopulmonary exercise test), Peak exercise work rate during maximal incremental exercise test (Highest work rate achieved during cardiopulmonary exercise test) and Change in forced vital capacity (Measured by spirometry; reported as liters)."

Answered by AI

Are there any available places for trial participants?

"The information available on clinicaltrials.gov attests to this study's current lack of recruitment, which was last updated on May 8th 2023. Despite the trial no longer seeking new participants, there are 441 other trials presently welcoming volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Breathing Training and Exercise Capacity in Non-CFB

Bryan Taylor 2024. "Breathing Training and Exercise Capacity in Non-CFB". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05860803.

All > Bronchiectasis